Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 82 results for "biocon under kiran mazumdar shaw"

Govt Under Fire Over Tax On Imports Of Life-Saving Drugs
Businessworld India

Withdrawal of customs duty exemption on life saving drugs face...

The withdrawal of customs duty exemption on imports of life-saving drugs came under criticism today with Biocon chief Kiran Mazumdar-Shaw saying levy of any kind of duty for these medicines does not resonate well with Indias affordable healthcare mission. Deccan Herald, 1 day ago

6 images for biocon under kiran mazumdar shaw

The Hindu, 1 day ago
NDTV Profit, 2 weeks ago
Business Standard India, 2 weeks ago
Money Today, 1 month ago
Hindustan Times, 2 weeks ago
Business Insider India, 2 weeks ago

Lift regulations on startups, help them flourish: Kiran Mazumdar-Shaw

Biocon chairman Kiran Mazumdar-Shaw has called for relaxing rules for startups to help them flourish, stating that there are several hidden regulations in the government's new policy. Even though the policy sounds very good, there are a lot of ...
 Yourstory.in2 weeks ago Biocon's Kiran Mazumdar-Shaw Calls for Lifting of Regulations on Start-Ups  NDTV Profit2 weeks ago Biocon Chief Calls for Lifting of Regulations on Start-Ups  NDTV2 weeks ago Lift regulations on startups: Kiran Mazumdar-Shaw  Economic Times2 weeks ago
Financial Express

Advanced Therapy for Treating Hepatitis C

File Photo of Kiran Mazumdar Shaw, the chairman and managing director of Biocon Limited Biocon has launched advanced novel therapy for the treatment of Hepatitis C at a lower price. CIMIVIR-L, a fixed dose combination of Ledipasvir 90 mg and ...
 EHealth Magazine1 month ago Biocon introduces therapy for treatment of Hepatitis C in India  Financial Express1 month ago

Kiran Mazumdar Shaw: Life science developments to look out for in 2016

These are exciting times for the life sciences sector as it builds on its understanding of the disease at the cellular and genetic level to usher in new and differentiated therapies into the market. Furthermore, biomedical advances are likely to ...
 Smart Investor1 month ago

Women entrepreneurs must focus on scale and good team

Bengaluru, Feb 4 Women entrepreneurs must focus on scale and building a good team, said Biocon chairperson Kiran Mazumdar Shaw on Thursday. "As women, we must focus on building scale. If you don't build scale, I really believe you will be at a ...
 ProKerala.com4 days ago 'Women entrepreneurs must focus on scale and good team'  SME Times4 days ago
Business Standard India

Biocon to conduct oral insulin trials on its own

Biopharma major Biocon Ltd will conduct on its own the next phase of clinical trials of its oral insulin Tregopil with a larger patient pool including in India, as the company expects the drug, after regulatory approvals, would offer it licensing ...
 Smart Investor1 week ago Biocon oral insulin Tregopil completes phase I study to move on to larger patient cohort for validation  PharmaBiz2 weeks ago
Business Standard India

Biocon net moves up by 13.3% to Rs.103 crore in Q3, R&D spending up by 45%

Biocon, a Rs. 3,000 crore plus pharma company from Bengaluru, has reported satisfactory financial performance during the third quarter ended December 2015 due to higher growth in contract research income. EBIDTA surged by 22.9 per cent to Rs. 209 ...
 PharmaBiz2 weeks ago Biocon net profit up 13% in Q3  Smart Investor2 weeks ago Biocon Q3 profit rises 13% to Rs 103 cr; Syngene lifts revenue  Moneycontrol.com2 weeks ago Biocon net up 13 percent in Q3 (Lead)  NetIndia123.com2 weeks ago
NDTV Profit

Syngene Appoints J Hunt as CEO-Designate

New Delhi : Syngene International, research arm of Biocon, on Monday appointed Jonathan Hunt as its CEO designate.Hunt will take charge after the retirement of current CEO Peter Bains in March, Syngene International said in aregulatory filing. ...
 NDTV Profit1 month ago Biocon arm Syngene names Jonathan Hunt as CEO-designate  Smart Investor1 month ago Syngene appoints Jonathan Hunt as CEO-designate  Economic Times1 month ago

Biocon Announces Data from Key Studies for Insulin Tregopil

Posted On: 2016-01-24 20:45:46 Biocon Ltd, Asia's premier biotechnology company, has announced key data on Insulin Tregopil (formerly referred to as IN-105) following Phase 1 studies that validate and provide the basis for the next phase of ...
 Equity Bulls2 weeks ago

Sajjan Jindal, Shaw among 19-member group to advise Karnataka on investments

BENGALURU: Karnataka has formed a group of industrialists to advise Large and Medium Industries Minister R.V.Deshpande on how the state could step up industrial investments. The small group of captains are also expected to play a role as Karnataka's ...
 Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
Get updated on latest news & your favorite topics right in your inbox!
More     Less